BONSPRI 20 MG
Ofatumumab
Public price
11.326,00 MAD
Active substance
Ofatumumab
Laboratory
NOVARTIS PHARMA MAROC
What is this medicine?
BONSPRI 20 MG contains Ofatumumab. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
Ofatumumab, Boite unitaire, 20 MG, Solution injectable en seringue pré-remplie de 0,4 ML
Common uses
Use is linked to the active substance, the selected indication, and the pharmaceutical form.
Class
ANTINEOPLASIQUES ET IMMUNOMODULATEURS
Laboratory
NOVARTIS PHARMA MAROC
Strength
20 MG
Form
Boite unitaire
Presentation
Solution injectable en seringue pré-remplie de 0,4 ML
Therapeutic class
ANTINEOPLASIQUES ET IMMUNOMODULATEURS
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 11.326,00 MAD